Showing results (81-90 of 140) with videos related to
Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|February 15, 2018
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?Dana L Casey, Ken L Pitter, Brian H Kushner, et al.Journal of Imaging Informatics in Medicine|June 17, 2024
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis DetectionSubhanik Purkayastha, Hrithwik Shalu, David Gutman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.Pediatric Blood & Cancer|November 2, 2007
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden, Christopher A Barker, Brian H Kushner, et al.Sarcoma|May 7, 2015
Myeloablative chemotherapy with autologous stem cell transplant for desmoplastic small round cell tumorChristopher J Forlenza, Brian H Kushner, Nancy Kernan, et al.Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.Pageof 14